日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Safety and Tolerability of Manual Push Administration of Subcutaneous IgPro20 at High Infusion Rates in Patients with Primary Immunodeficiency: Findings from the Manual Push Administration Cohort of the HILO Study

在原发性免疫缺陷患者中，以高输注速率手动推注皮下注射IgPro20的安全性和耐受性：HILO研究手动推注给药队列的研究结果

期刊:Journal of Clinical Immunology
影响因子:5.7
doi:10.1007/s10875-020-00876-6
Cowan, Juthaporn; Bonagura, Vincent R; Lugar, Patricia L; Maglione, Paul J; Patel, Niraj C; Vinh, Donald C; Hofmann, Jutta H; Praus, Michaela; Rojavin, Mikhail A
免疫/内分泌
发表日期：2021
文献求助 收藏

Safety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary Immunodeficiency: Findings from the Pump-Assisted Administration Cohorts of the HILO Study

在原发性免疫缺陷患者中，高输注参数下皮下注射IgPro20的安全性和耐受性：HILO研究泵辅助给药队列的研究结果

期刊:Journal of Clinical Immunology
影响因子:5.7
doi:10.1007/s10875-020-00912-5
Anderson, John T; Bonagura, Vincent R; Cowan, Juthaporn; Hsu, Connie; Mustafa, S Shahzad; Patel, Niraj C; Routes, John M; Sriaroon, Panida; Vinh, Donald C; Hofmann, Jutta H; Praus, Michaela; Rojavin, Mikhail A
免疫/内分泌
发表日期：2021
文献求助 收藏

Pharmacokinetic Analysis of Weekly Versus Biweekly IgPro20 Dosing in Patients With Primary Immunodeficiency

原发性免疫缺陷患者每周一次与每两周一次IgPro20给药方案的药代动力学分析

期刊:Clinical Pharmacology in Drug Development
影响因子:1.8
doi:10.1002/cpdd.753
Rojavin, Mikhail A; Chapdelaine, Hugo; Tortorici, Michael A; Praus, Michaela; Baheti, Gautam; Zhang, Ying; Hofmann, Jutta; Labrosse, Roxane; Dicaire, Renée; Haddad, Elie
免疫/内分泌
发表日期：2020
文献求助 收藏

Long-Term Efficacy and Safety of Hizentra® in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 Trials

Hizentra®治疗日本、欧洲和美国原发性免疫缺陷患者的长期疗效和安全性：7项3期临床试验的回顾

期刊:Journal of Clinical Immunology
影响因子:5.7
doi:10.1007/s10875-018-0560-5
Jolles, Stephen; Rojavin, Mikhail A; Lawo, John-Philip; Nelson, Robert Jr; Wasserman, Richard L; Borte, Michael; Tortorici, Michael A; Imai, Kohsuke; Kanegane, Hirokazu
免疫/内分泌
发表日期：2018
文献求助 收藏

Treatment Satisfaction with Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency: a Pooled Analysis of Six Hizentra® Studies

原发性免疫缺陷患者接受皮下注射免疫球蛋白替代疗法的治疗满意度：六项Hizentra®研究的汇总分析

期刊:Journal of Clinical Immunology
影响因子:5.7
doi:10.1007/s10875-018-0562-3
Mallick, Rajiv; Jolles, Stephen; Kanegane, Hirokazu; Agbor-Tarh, Dominique; Rojavin, Mikhail
免疫/内分泌
发表日期：2018
文献求助 收藏

Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema

静脉注射C1抑制剂浓缩液用于遗传性血管性水肿长期预防的疗效和安全性

期刊:
影响因子:
doi:10.2500/ar.2017.8.0192
Craig, Timothy; Shapiro, Ralph; Vegh, Arthur; Baker, James W; Bernstein, Jonathan A; Busse, Paula; Magerl, Markus; Martinez-Saguer, Inmaculada; Riedl, Marc A; Lumry, William; Williams-Herman, Debora; Edelman, Jonathan; Feuersenger, Henrike; Machnig, Thomas; Rojavin, Mikhail
发表日期：2017
文献求助 收藏

Quantitative Evidence of Wear-Off Effect at the End of the Intravenous IgG (IVIG) Dosing Cycle in Primary Immunodeficiency

原发性免疫缺陷患者静脉注射免疫球蛋白G（IVIG）给药周期结束时疗效减退效应的定量证据

期刊:Journal of Clinical Immunology
影响因子:5.7
doi:10.1007/s10875-016-0243-z
Rojavin, Mikhail A; Hubsch, Alphonse; Lawo, John-Philip
免疫/内分泌
发表日期：2016
文献求助 收藏

Use of a C1 Inhibitor Concentrate in Adults ≥65 Years of Age with Hereditary Angioedema: Findings from the International Berinert(®) (C1-INH) Registry

C1抑制剂浓缩液在≥65岁患有遗传性血管性水肿的成年人中的应用：来自国际Berinert®（C1-INH）注册研究的结果

期刊:Drugs & Aging
影响因子:3.8
doi:10.1007/s40266-016-0403-0
Bygum, Anette; Martinez-Saguer, Inmaculada; Bas, Murat; Rosch, Jeffrey; Edelman, Jonathan; Rojavin, Mikhail; Williams-Herman, Debora
发表日期：2016
文献求助 收藏

Efficacy and safety of IgPro20, a subcutaneous immunoglobulin, in Japanese patients with primary immunodeficiency diseases

皮下注射免疫球蛋白IgPro20治疗日本原发性免疫缺陷病患者的疗效和安全性

期刊:Journal of Clinical Immunology
影响因子:5.7
doi:10.1007/s10875-013-9985-z
Kanegane, Hirokazu; Imai, Kohsuke; Yamada, Masafumi; Takada, Hidetoshi; Ariga, Tadashi; Bexon, Martin; Rojavin, Mikhail; Hu, Wilson; Kobayashi, Midori; Lawo, John-Philip; Nonoyama, Shigeaki; Hara, Toshiro; Miyawaki, Toshio
免疫/内分泌
发表日期：2014
文献求助 收藏

Clinical experience with an L-proline–stabilized 10 %intravenous immunoglobulin (Privigen®): real-life effectiveness and tolerability

L-脯氨酸稳定的10%静脉注射免疫球蛋白（Privigen®）的临床经验：真实世界的有效性和耐受性

期刊:Journal of Clinical Immunology
影响因子:5.7
doi:10.1007/s10875-014-0070-z
Dorsey, Morna J; Ho, Viet; Mabudian, Mohsen; Soler-Palacín, Pere; Domínguez-Pinilla, Nerea; Rishi, Radha; Rishi, Rahul; Wong, Duane; Rojavin, Mikhail; Hubsch, Alphonse; Berger, Melvin
免疫/内分泌
发表日期：2014
文献求助 收藏